Showing results (171-180 of 211) with videos related to
Sort By:
Pageof 22
Cancer Research|March 15, 1991
myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimensJ Brennan, T O'Connor, R W Makuch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancerD C Ihde, J L Mulshine, B S Kramer, et al.Kansas Journal of Medicine|December 6, 2019
Exploring Latinidad, Migration Processes, and Immigrant Experiences: Experiences Influencing Latino HealthEvelyn Arana-Chicas, Erin Ihde, Francisco Cartujano-Barrera, et al.Annals of Internal Medicine|September 1, 1985
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-upB E Johnson, D C Ihde, P A Bunn, et al.Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.Journal of the National Cancer Institute|August 2, 1989
MDR1 gene expression in lung cancerS L Lai, L J Goldstein, M M Gottesman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostateE J Seifter, P A Bunn, M H Cohen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.Medicine|January 1, 1982
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceS T Rosen, J Aisner, R W Makuch, et al.Pageof 22